BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 33417889)

  • 1. A dyadic approach to the delineation of diagnostic entities in clinical genomics.
    Biesecker LG; Adam MP; Alkuraya FS; Amemiya AR; Bamshad MJ; Beck AE; Bennett JT; Bird LM; Carey JC; Chung B; Clark RD; Cox TC; Curry C; Dinulos MBP; Dobyns WB; Giampietro PF; Girisha KM; Glass IA; Graham JM; Gripp KW; Haldeman-Englert CR; Hall BD; Innes AM; Kalish JM; Keppler-Noreuil KM; Kosaki K; Kozel BA; Mirzaa GM; Mulvihill JJ; Nowaczyk MJM; Pagon RA; Retterer K; Rope AF; Sanchez-Lara PA; Seaver LH; Shieh JT; Slavotinek AM; Sobering AK; Stevens CA; Stevenson DA; Tan TY; Tan WH; Tsai AC; Weaver DD; Williams MS; Zackai E; Zarate YA
    Am J Hum Genet; 2021 Jan; 108(1):8-15. PubMed ID: 33417889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular Genetics of Cystic Fibrosis Transmembrane Conductance Regulator: Genotype and Phenotype.
    Sosnay PR; Raraigh KS; Gibson RL
    Pediatr Clin North Am; 2016 Aug; 63(4):585-98. PubMed ID: 27469177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Applying Cystic Fibrosis Transmembrane Conductance Regulator Genetics and CFTR2 Data to Facilitate Diagnoses.
    Sosnay PR; Salinas DB; White TB; Ren CL; Farrell PM; Raraigh KS; Girodon E; Castellani C
    J Pediatr; 2017 Feb; 181S():S27-S32.e1. PubMed ID: 28129809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Precision Genomic Medicine in Cystic Fibrosis.
    Chang EH; Zabner J
    Clin Transl Sci; 2015 Oct; 8(5):606-10. PubMed ID: 26073768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current Status of Genetic Diagnosis Laboratories and Frequency of Genetic Variants Associated with Cystic Fibrosis through a Newborn-Screening Program in Turkey.
    Bozdogan ST; Mujde C; Boga I; Sonmezler O; Hanta A; Rencuzogullari C; Ozcan D; Altintas DU; Bisgin A
    Genes (Basel); 2021 Jan; 12(2):. PubMed ID: 33572515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genotype and phenotype in cystic fibrosis.
    Zielenski J
    Respiration; 2000; 67(2):117-33. PubMed ID: 10773783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. R248G cystic fibrosis transmembrane conductance regulator mutation in three siblings presenting with recurrent acute pancreatitis and reproductive issues: a case series.
    Villalona S; Glover-López G; Ortega-García JA; Moya-Quiles R; Mondejar-López P; Martínez-Romero MC; Rigabert-Montiel M; Pastor-Vivero MD; Sánchez-Solís M
    J Med Case Rep; 2017 Feb; 11(1):42. PubMed ID: 28196530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical implications of cystic fibrosis transmembrane conductance regulator mutations.
    Mickle JE; Cutting GR
    Clin Chest Med; 1998 Sep; 19(3):443-58, v. PubMed ID: 9759548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenotypic variability in a family with pancreatitis and cystic fibrosis sharing common mild CFTR mutation: report on CFTR mutations and their phenotypic variability.
    Alghisi F; Bella S; Lucidi V; Angioni A; Tomaiuolo AC; D'Apice MR; Gambardella S; Novelli G
    Pancreas; 2009 Jan; 38(1):109-10. PubMed ID: 19106752
    [No Abstract]   [Full Text] [Related]  

  • 10. [Molecular basis of phenotype heterogeneity in cystic fibrosis].
    Bienvenu T
    Ann Biol Clin (Paris); 1997; 55(2):113-21. PubMed ID: 9180964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetics of Cystic Fibrosis: Clinical Implications.
    Egan ME
    Clin Chest Med; 2016 Mar; 37(1):9-16. PubMed ID: 26857764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations in pancreatitis.
    Ooi CY; Durie PR
    J Cyst Fibros; 2012 Sep; 11(5):355-62. PubMed ID: 22658665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expanded carrier screening and preimplantation genetic diagnosis in a couple who delivered a baby affected with congenital factor VII deficiency.
    He WB; Tan YQ; Hu X; Li W; Xiong B; Luo KL; Gong F; Lu GX; Lin G; Du J
    BMC Med Genet; 2018 Jan; 19(1):15. PubMed ID: 29368589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Towards the pharmacogenomics of cystic fibrosis.
    Sangiuolo F; D'Apice MR; Bruscia E; Lucidi V; Novelli G
    Pharmacogenomics; 2002 Jan; 3(1):75-87. PubMed ID: 11966405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genotypes and phenotypes in cystic fibrosis and cystic fibrosis transmembrane regulator-related disorders.
    Bombieri C; Seia M; Castellani C
    Semin Respir Crit Care Med; 2015 Apr; 36(2):180-93. PubMed ID: 25826586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between genotype and phenotype for the CFTR gene W846X mutation.
    Duguépéroux I; Bellis G; Férec C; Gillet D; Scotet V; De Braekeleer M;
    J Med Genet; 2002 Jun; 39(6):E32. PubMed ID: 12070264
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of genotype on phenotype and mortality in cystic fibrosis: a retrospective cohort study.
    McKone EF; Emerson SS; Edwards KL; Aitken ML
    Lancet; 2003 May; 361(9370):1671-6. PubMed ID: 12767731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cystic Fibrosis: A Review of Associated Phenotypes, Use of Molecular Diagnostic Approaches, Genetic Characteristics, Progress, and Dilemmas.
    Brennan ML; Schrijver I
    J Mol Diagn; 2016 Jan; 18(1):3-14. PubMed ID: 26631874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical presentation of mild cystic fibrosis in a Serbian patient homozygous for the CFTR mutation c.1393-1G>A.
    Nikolic A; Radlovic N; Dinic J; Milosevic K; Radojkovic D
    J Cyst Fibros; 2014 Jan; 13(1):111-3. PubMed ID: 23933162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishing a diagnosis of cystic fibrosis.
    Southern KW; Peckham D
    Chron Respir Dis; 2004; 1(4):205-10. PubMed ID: 16281647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.